Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice

The deterioration of brain glucose metabolism predates the clinical onset of Alzheimer’s disease (AD). Medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively improve brain glucose metabolism and decrease the expression of AD-related proteins. However, the effects of the combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zehao, Zhang, Dalong, Cheng, Cheng, Lin, Zhenzhen, Zhou, Dezheng, Sun, Yue, Li, Wen, Yan, Jing, Luo, Suhui, Qian, Zhiyong, Li, Zhenshu, Huang, Guowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574179/
https://www.ncbi.nlm.nih.gov/pubmed/37836528
http://dx.doi.org/10.3390/nu15194244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574179/
https://www.ncbi.nlm.nih.gov/pubmed/37836528
http://dx.doi.org/10.3390/nu15194244

Ejemplares similares